No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Island Pharmaceuticals Progresses Dengue Drug Trial
Island Pharmaceuticals Reallocates Grant Funding to Dengue Fever Trial; Shares Rally 13%
Island Pharmaceuticals Advances Dengue Fever Treatment With Promising ISLA-101 Study Results
Island Pharmaceuticals Targets $1.95 Million in New Capital Raise
Australia Shares Fall as Central Bank Keeps Rates Steady
Island Pharmaceuticals Achieves Primary Endpoint in Dengue Drug Ascending Dose Study
No Data